Publications found:
211
Sort by:
The 2027-2032 World Outlook for Asthma Treatments
US$ 1,195.00
This study covers the world outlook for asthma treatments across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for asthma treatments. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
Global Inhalation Therapy Nebulizer Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... manufacturers of Inhalation Therapy Nebulizer, with price, sales, revenue and global market share of Inhalation Therapy Nebulizer in 2017 and 2018. Chapter 3, the Inhalation Therapy Nebulizer competitive situation, sales, revenue and global market share ...
January 2026
111 pages
The 2027-2032 World Outlook for Anti-Infective Agents
US$ 1,195.00
This study covers the world outlook for anti-infective agents across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for anti-infective agents. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
289 pages
The 2027-2032 World Outlook for Asthma Therapeutics
US$ 1,195.00
This study covers the world outlook for asthma therapeutics across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for asthma therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
288 pages
The 2027-2032 World Outlook for Alpha-1 Antitrypsin Drugs
US$ 1,195.00
This study covers the world outlook for alpha-1 antitrypsin drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Bronchitis Treatments
US$ 1,195.00
This study covers the world outlook for bronchitis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Bronchodilators
US$ 1,195.00
This study covers the world outlook for bronchodilators across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
Reactive Airway Disease Market - 2024-2031
US$ 3,400.00
The Reactive Airway Disease Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...
December 2025
49 pages
Inhaler Solution Market Size, Share & Trends Analysis Report By Inhaler Type (Pressurized Metered-Dose Inhalers (pMDIs), Dry-Powder Inhalers (DPIs)), By Drug Class, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global inhaler solution market size was estimated at USD 31.42 billion in 2025 and is projected to reach USD 49.79 billion by 2033, growing at a CAGR of 5.9% from 2026 to 2033. This growth is pri...
December 2025
150 pages
Anti-Pollution Nasal Spray Market Size, Share & Trends Analysis By Product (Pollution Defense Products, Hydrating Nasal Sprays, Symptomatic Relief Nasal Sprays, Cleansing Nasal Sprays), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global anti-pollution nasal spray market size was estimated at USD 8.35 billion in 2025 and is projected to reach USD 13.30 billion by 2033, growing at a CAGR of 6.10% from 2026 to 2033. The high...
December 2025
172 pages
Pneumonia Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Infection Type (Hospital-acquired Pneumonia [HAP], Community-acquired Pneumonia [CAP], Ventilator-associated Pneumonia [VAP]), By Type (Drugs, Preventive Vaccines, Oxygen Therapy), By Drug Class (Antibacterial Drugs, Antiviral Drugs, Antifungal Drugs), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Pneumonia Therapeutics Market will grow from USD 2.91 Billion in 2024 to USD 4.56 Billion by 2030 at a 7.76% CAGR. Pneumonia therapeutics comprise a class of pharmaceutical interventions an...
December 2025
185 pages
Non-Cystic Fibrosis Bronchiectasis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Surgery, Physiotherapy, Vaccination, Airway Pharmacotherapy, Antibiotics, Others), By Diagnosis (CT scan, Bronchoscopy, Chest X-ray, Lung function, Sputum culture test, Blood tests, Others), By End use (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Non-Cystic Fibrosis Bronchiectasis Market, valued at USD 3.71 Billion in 2024, is projected to experience a CAGR of 5.30% to reach USD 5.06 Billion by 2030. The Global Non-Cystic Fibrosis B...
December 2025
185 pages
Respiratory Diagnostics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Instruments and Devices, Assays & Reagents, Services & Software), By Test Type (Mechanical Tests, OSA Diagnostic Test, Imaging Tests, Traditional Diagnostic Test, Molecular Diagnostic Tests), By Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-Use (Hospitals and Clinics, Diagnostics Laboratory, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Respiratory Diagnostics Market, valued at USD 6.02 Billion in 2024, is projected to experience a CAGR of 7.10% to reach USD 9.09 Billion by 2030. The global respiratory diagnostics market e...
December 2025
185 pages
Nasal Antihistamines Market - 2024-2031
US$ 3,400.00
Nasal Antihistamines Marketis is growing with a CAGR of 4.40% during the forecast period 2026-2035. The Nasal Antihistamines Market emerges as a key focus in DataM Intelligence latest in-depth analysi...
November 2025
46 pages
Acute Respiratory Disease Diagnostics Market Size, Share & Trends Analysis Report By Test (Molecular Diagnostics, Antigen-based Rapid Tests), By Pathogen (Viral Infections, Bacterial Infections), By End-use (Hospitals & Clinics, Home Testing), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global acute respiratory disease diagnostics market size was estimated at USD 5.49 billion in 2024 and is projected to reach USD 10.71 billion by 2033, growing at a CAGR of 7.01% from 2025 to 2033...
November 2025
150 pages
Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class, By Type (Branded, Generics), By Route of Administration (Oral, Intravenous/Subcutaneous, Inhalational), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global pulmonary arterial hypertension market size is expected to reach USD 9.3 billion by 2026, according to a new report ... the development of PAH foster the regional market growth Major players operating in the pulmonary arterial hypertension market include GlaxoSmithKline Plc.; Actelion Pharmaceuticals, ...
November 2025
150 pages
U.S. Asthma Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Anti-inflammatory, Bronchodilators), By Device Type (Inhalers, Nebulizers), By Route of Administration (Oral, Inhaled), By Product, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The U.S. asthma therapeutics market size was estimated at USD 13.00 billion in 2024 and is projected to reach USD 19.20 billion by 2033, growing at a CAGR of 4.5% from 2025 to 2033. The rising number...
October 2025
100 pages
Acute Respiratory Distress Syndrome (Ards) Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Diagnosis, Treatment), By Cause (COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes), By Severity, By End User
US$ 3,950.00
The Acute Respiratory Distress Syndrome (Ards) Market is valued at USD 1.8 billion in 2025 and is projected to grow at a CAGR of 10.5% to reach USD 4.4 billion by 2034.The acute respiratory distress s...
October 2025
160 pages
Chronic Obstructive Pulmonary Disease (Copd) Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Combination Therapy, Bronchodilators, Corticosteroids, Phosphodiesterase Type 4 Inhibitor, Mucokinetics, Other Drug Classes), By Type (Chronic Bronchitis, Emphysema), By End-User
US$ 3,950.00
The Chronic Obstructive Pulmonary Disease (Copd) Treatment Market is valued at USD 18.6 billion in 2025 and is projected to grow at a CAGR of 4.8% to reach USD 28.2 billion by 2034.The Chronic Obstruc...
October 2025
160 pages
Emphysema Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment (Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments), By Distribution Channel (Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies), By End-User
US$ 3,950.00
The Emphysema Treatment Market is valued at USD 7 billion in 2025 and is projected to grow at a CAGR of 6.8% to reach USD 12.6 billion by 2034. Market Overview: Emphysema Treatment Market The emphysem...
October 2025
160 pages
